Eli Lilly maintains M&A streak with $202m Engage Bio buyout

FierceBiotechLilly’s triple-G drug helps patients lose roughly a quarter of weight, showcasing competitive profile

FierceBiotechBetting on biotech: Prediction markets set sights on clinical trials

Endpoints NewsBioMarin to seek further approval of Voxzogo in form of short stature

Endpoints NewsIncyte signs AI deals with Genesis Molecular AI, Edison Scientific

BioWorldSizing up an epidemic, with diagnostics and bioinformatics

Endpoints NewsBMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campus

BioPharma DiveIn Alzheimer’s, Bristol Myers sees big promise beyond amyloid

BioWorldGertrude Biomedical discovers new SOX18 inhibitors

BioWorldHansoh identifies new PI3Kα mutant inhibitors

BioWorldNampt activators disclosed in Nanjing Reju Therapeutics patent

Promega BlogTiny Edits, Big Harvests: How a Massive Mutation Screen Could Transform Crop Engineering

PharmaVoiceChina’s biotech rise sparks new US industry alliance